All stock lists
Space Exploration Technologies Corp (NASDAQ:SPCX)
US · Delayed Price · Currency is USD
147.49+2.74 (+1.89%)
Insider Score
––Not scored
SPCX Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
SPCX analyst forecast
SPCX analyst consensus
Moderate Buy21 ratings
Buy 17 Hold 4 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
SPCX 12-month price target
$210.84+41.1% upsideaverage of 19 firms
$401.00High
$75.00Low
Best analysts covering SPCX
No firm covering SPCX has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
SPCX analyst ratings
| Analyst | Firm | Rating | Price target | Upside | Action | Date |
|---|---|---|---|---|---|---|
| Bernstein | — | $267.00 | +81.0% | — | 2026-10-26 | |
| Bernstein | — | $268.00 | +81.7% | — | 2026-10-26 | |
| — | B of A Securities | Buy | — | — | Reiterated | 2026-10-22 |
| Pivotal Research | Buy | $260.00 | +60.3% | Reiterated | 2026-10-22 | |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-10-21 |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-10-21 |
| Susquehanna | Neutral | $176.00 | +19.1% | Reiterated | 2026-10-21 | |
| — | Keybanc | Sector Weight | — | — | Reiterated | 2026-10-21 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-10-21 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-10-21 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-10-21 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-10-21 |
| — | Macquarie | Outperform | — | — | Reiterated | 2026-10-21 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-10-21 |
| — | UBS | Buy | — | — | Reiterated | 2026-10-21 |
| — | Needham | Buy | — | — | Reiterated | 2026-10-21 |
| Goldman Sachs | — | $245.00 | +65.8% | — | 2026-10-21 | |
| Mizuho Securities | — | $205.00 | +38.7% | — | 2026-10-21 | |
| — | Macquarie | Outperform | — | — | Reiterated | 2026-10-20 |
| Evercore ISI Group | Outperform | $275.00 | +85.0% | Reiterated | 2026-10-16 | |
| Pivotal Research | — | $230.00 | +41.5% | — | 2026-10-12 | |
| — | TD Cowen | Buy | — | — | Reiterated | 2026-10-09 |
| — | Susquehanna | Neutral | — | — | Reiterated | 2026-10-07 |
| — | Macquarie | Outperform | — | — | Reiterated | 2026-09-30 |
| — | Deutsche Bank | Buy | — | — | Reiterated | 2026-09-28 |
| — | MoffettNathanson | Neutral | — | — | Reiterated | 2026-09-14 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-09-08 |
| Pivotal Research | — | $220.00 | +48.7% | — | 2026-09-08 | |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-09-02 |
| Wolfe Research | Outperform | $175.00 | +26.9% | Reiterated | 2026-08-26 | |
| — | UBS | Buy | — | — | Reiterated | 2026-08-17 |
| Phillip Securities | — | $75.00 | -46.4% | — | 2026-08-17 | |
| Argus Research | Buy | $160.00 | +39.2% | Upgraded | 2026-08-07 | |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-08-05 |
| — | Needham | Buy | — | — | Reiterated | 2026-08-05 |
| Piper Sandler | Neutral | $140.00 | +11.7% | Reiterated | 2026-08-05 | |
| — | Macquarie | Outperform | — | — | Reiterated | 2026-08-05 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-08-05 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-08-03 |
| — | Macquarie | Outperform | — | — | Reiterated | 2026-08-03 |
| — | Macquarie | Outperform | — | — | Reiterated | 2026-07-31 |
| HSBC | — | $115.00 | -2.7% | — | 2026-07-23 | |
| — | Macquarie | Outperform | — | — | Reiterated | 2026-07-21 |
| — | Needham | Buy | — | — | Reiterated | 2026-07-15 |
| Cantor Fitzgerald | — | $246.00 | +53.3% | — | 2026-07-07 | |
| MoffettNathanson | — | $131.00 | -18.3% | — | 2026-07-07 | |
| Stifel Nicolaus | — | $190.00 | +18.4% | — | 2026-07-07 | |
| Wells Fargo | — | $230.00 | +43.4% | — | 2026-07-07 | |
| Morgan Stanley | — | $300.00 | +87.0% | — | 2026-07-07 | |
| Oppenheimer | Outperform | $250.00 | +30.3% | Reiterated | 2026-06-18 | |
| Arete Research | — | $401.00 | +109.1% | — | 2026-06-18 | |
| Oppenheimer | — | $190.00 | +40.7% | — | 2026-06-11 | |
| New Street | — | $165.00 | +22.2% | — | 2026-06-10 |
SPCX earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-05-20 | 0.00 | -1.19 | $0 | $4.69B |
| 2026-08-04 | -0.23 | -0.09 | $6.83B | $7.81B |
| 2026-10-20 | 0.13 | 0.35 | $12.87B | $14.57B |
| 2027-02-25 | 0.40 | 0.00 | $22.46B | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.